138 related articles for article (PubMed ID: 28218211)
1. A Model Predicting Lymph Node Status for Patients with Clinical Stage T1aN0-2M0 Nonsmall Cell Lung Cancer.
Zang RC; Qiu B; Gao SG; He J
Chin Med J (Engl); 2017 Feb; 130(4):398-403. PubMed ID: 28218211
[TBL] [Abstract][Full Text] [Related]
2. [A clinical prediction model for N2 lymph node metastasis in clinical stage I non-small cell lung cancer].
Chen KZ; Yang F; Wang X; Jiang GC; Li JF; Wang J
Beijing Da Xue Xue Bao Yi Xue Ban; 2015 Apr; 47(2):295-301. PubMed ID: 25882948
[TBL] [Abstract][Full Text] [Related]
3. A prediction model for lymph node metastases using pathologic features in patients intraoperatively diagnosed as stage I non-small cell lung cancer.
Zhao F; Zhou Y; Ge PF; Huang CJ; Yu Y; Li J; Sun YG; Meng YC; Xu JX; Jiang T; Zhang ZX; Sun JP; Wang W
BMC Cancer; 2017 Apr; 17(1):267. PubMed ID: 28407802
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a clinical prediction model for N2 lymph node metastasis in non-small cell lung cancer.
Chen K; Yang F; Jiang G; Li J; Wang J
Ann Thorac Surg; 2013 Nov; 96(5):1761-8. PubMed ID: 23998401
[TBL] [Abstract][Full Text] [Related]
5. A prediction model for N2 disease in T1 non-small cell lung cancer.
Zhang Y; Sun Y; Xiang J; Zhang Y; Hu H; Chen H
J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1360-4. PubMed ID: 22819364
[TBL] [Abstract][Full Text] [Related]
6. A Texture Analysis-Based Prediction Model for Lymph Node Metastasis in Stage IA Lung Adenocarcinoma.
Gu Y; She Y; Xie D; Dai C; Ren Y; Fan Z; Zhu H; Sun X; Xie H; Jiang G; Chen C
Ann Thorac Surg; 2018 Jul; 106(1):214-220. PubMed ID: 29550204
[TBL] [Abstract][Full Text] [Related]
7. Predictive factors for node metastasis in patients with clinical stage I non-small cell lung cancer.
Cho S; Song IH; Yang HC; Kim K; Jheon S
Ann Thorac Surg; 2013 Jul; 96(1):239-45. PubMed ID: 23673071
[TBL] [Abstract][Full Text] [Related]
8. [Risk factor analysis of mediastinal lymph node metastasis in non-small cell lung cancer patients and the strategy of mediastinoscopy prior to surgery].
Wang X; Zheng L; Zhang SY; Xie ZM; Yu H; Su XD; Wang JY; Huang ZF; Yang MT; Rong TH
Zhonghua Zhong Liu Za Zhi; 2009 Jun; 31(6):456-9. PubMed ID: 19950559
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implication of metastasis limited to segmental (level 13) and/or subsegmental (level 14) lymph nodes in patients with surgically resected nonsmall cell lung carcinoma and pathologic N1 lymph node status.
Maeshima AM; Tsuta K; Asamura H; Tsuda H
Cancer; 2012 Sep; 118(18):4512-8. PubMed ID: 22282325
[TBL] [Abstract][Full Text] [Related]
10. Frequency of noncontiguous lymph node involvement in patients with resectable nonsmall cell lung carcinoma.
Bonner JA; Garces YI; Sawyer TE; Gould PM; Foote RL; Deschamps C; Lange CM; Li H
Cancer; 1999 Oct; 86(7):1159-64. PubMed ID: 10506699
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
[TBL] [Abstract][Full Text] [Related]
12. Predictability and Utility of Contrast-Enhanced CT on Occult Lymph Node Metastasis for Patients with Clinical Stage IA-IIA Lung Adenocarcinoma: A Double-Center Study.
Zhao F; Zhao Y; Zhang Y; Sun H; Ye Z; Zhou G
Acad Radiol; 2023 Dec; 30(12):2870-2879. PubMed ID: 37003873
[TBL] [Abstract][Full Text] [Related]
13. The significance of one-station N2 disease in the prognosis of patients with nonsmall-cell lung cancer.
Misthos P; Sepsas E; Kokotsakis J; Skottis I; Lioulias A
Ann Thorac Surg; 2008 Nov; 86(5):1626-30. PubMed ID: 19049761
[TBL] [Abstract][Full Text] [Related]
14. Occult nodal metastasis in patients with non-small cell lung cancer at clinical stage IA by PET/CT.
Park HK; Jeon K; Koh WJ; Suh GY; Kim H; Kwon OJ; Chung MP; Lee KS; Shim YM; Han J; Um SW
Respirology; 2010 Nov; 15(8):1179-84. PubMed ID: 20573058
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the proposed classifications for the revision of N descriptors for non-small-cell lung cancer.
Lee GD; Kim DK; Moon DH; Joo S; Hwang SK; Choi SH; Kim HR; Kim YH; Park SI
Eur J Cardiothorac Surg; 2016 Feb; 49(2):580-8. PubMed ID: 25890940
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
Qiu C; Dong W; Su B; Liu Q; Du J
J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264
[TBL] [Abstract][Full Text] [Related]
17. [Application of a Radiomics Model for Preding Lymph Node Metastasis in Non-small Cell Lung Cancer].
Zhu J; Xu WG; Xiao H; Zhou Y
Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 May; 50(3):373-378. PubMed ID: 31631606
[TBL] [Abstract][Full Text] [Related]
18. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
[TBL] [Abstract][Full Text] [Related]
19. Preoperative Risk Assessment of Lymph Node Metastasis in cT1 Lung Cancer: A Retrospective Study from Eastern China.
Zhang C; Pang G; Ma C; Wu J; Wang P; Wang K
J Immunol Res; 2019; 2019():6263249. PubMed ID: 31886306
[TBL] [Abstract][Full Text] [Related]
20. Resectable left lower lobe non-small cell lung cancer with lymph node metastasis is related to unfavorable outcomes.
Ye WF; Xie X; Yang H; Luo KJ; Liu QW; Zheng YZ; Wang JY
Chin J Cancer; 2016 Jan; 35():7. PubMed ID: 26738896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
